Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 115 results
Author
Title
Type
Year
2015
Feng FY
,
de Bono JS
,
Rubin MA
,
Knudsen KE
. 2015.
Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function.
.
Mol Cell. 58(6):925-34.
Mateo J
,
Carreira S
,
Sandhu S
,
Miranda S
,
Mossop H
,
Perez-Lopez R
,
Rodrigues DNava
,
Robinson D
,
Omlin A
,
Tunariu N
et al.
. 2015.
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
.
N Engl J Med. 373(18):1697-708.
Barbieri CE
,
Rubin MA
. 2015.
Genomic rearrangements in prostate cancer.
.
Curr Opin Urol. 25(1):71-6.
Rubin MA
. 2015.
Health: Make precision medicine work for cancer care.
.
Nature. 520(7547):290-1.
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative clinical genomics of advanced prostate cancer.
.
Cell. 161(5):1215-28.
Mosquera J-M
,
Varma S
,
Pauli C
,
MacDonald TY
,
Yashinskie JJ
,
Varga Z
,
Sboner A
,
Moch H
,
Rubin MA
,
Shin SJ
. 2015.
MAGI3-AKT3 fusion in breast cancer amended.
.
Nature. 520(7547):E11-2.
Gillessen S
,
Omlin A
,
Attard G
,
de Bono JS
,
Efstathiou E
,
Fizazi K
,
Halabi S
,
Nelson PS
,
Sartor O
,
Smith MR
et al.
. 2015.
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
.
Ann Oncol. 26(8):1589-604.
Cancer Genome Atlas Research Network
. 2015.
The Molecular Taxonomy of Primary Prostate Cancer.
.
Cell. 163(4):1011-25.
Akamatsu S
,
Wyatt AW
,
Lin D
,
Lysakowski S
,
Zhang F
,
Kim S
,
Tse C
,
Wang K
,
Mo F
,
Haegert A
et al.
. 2015.
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.
.
Cell Rep. 12(6):922-36.
Boysen G
,
Barbieri CE
,
Prandi D
,
Blattner M
,
Chae S-S
,
Dahija A
,
Nataraj S
,
Huang D
,
Marotz C
,
Xu L
et al.
. 2015.
SPOP mutation leads to genomic instability in prostate cancer.
.
Elife. 4
Rubin MA
. 2015.
Toward a prostate cancer precision medicine.
.
Urol Oncol. 33(2):73-4.
Beltran H
,
Eng K
,
Mosquera JMiguel
,
Sigaras A
,
Romanel A
,
Rennert H
,
Kossai M
,
Pauli C
,
Faltas B
,
Fontugne J
et al.
. 2015.
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
.
JAMA Oncol. 1(4):466-74.
2014
Chakravarty D
,
Sboner A
,
Nair SS
,
Giannopoulou E
,
Li R
,
Hennig S
,
Mosquera JMiguel
,
Pauwels J
,
Park K
,
Kossai M
et al.
. 2014.
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.
.
Nat Commun. 5:5383.
Epstein JI
,
Amin MB
,
Beltran H
,
Lotan TL
,
Mosquera J-M
,
Reuter VE
,
Robinson BD
,
Troncoso P
,
Rubin MA
. 2014.
Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.
.
Am J Surg Pathol. 38(6):756-67.
Park K
,
Dalton JT
,
Narayanan R
,
Barbieri CE
,
Hancock ML
,
Bostwick DG
,
Steiner MS
,
Rubin MA
. 2014.
TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.
.
J Clin Oncol. 32(3):206-11.
2013
Mosquera JMiguel
,
Beltran H
,
Park K
,
MacDonald TY
,
Robinson BD
,
Tagawa ST
,
Perner S
,
Bismar TA
,
Erbersdobler A
,
Dhir, iv R
et al.
. 2013.
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.
.
Neoplasia. 15(1):1-10.
Lin P-C
,
Chiu Y-L
,
Banerjee S
,
Park K
,
Mosquera JMiguel
,
Giannopoulou E
,
Alves P
,
Tewari AK
,
Gerstein MB
,
Beltran H
et al.
. 2013.
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression.
.
Cancer Res. 73(3):1232-44.
Demichelis F
,
Garraway LA
,
Rubin MA
. 2013.
Molecular archeology: unearthing androgen-induced structural rearrangements in prostate cancer genomes.
.
Cancer Cell. 23(2):133-5.
Beltran H
,
Rubin MA
. 2013.
New strategies in prostate cancer: translating genomics into the clinic.
.
Clin Cancer Res. 19(3):517-23.
Baca SC
,
Prandi D
,
Lawrence MS
,
Mosquera JMiguel
,
Romanel A
,
Drier Y
,
Park K
,
Kitabayashi N
,
MacDonald TY
,
Ghandi M
et al.
. 2013.
Punctuated evolution of prostate cancer genomes.
.
Cell. 153(3):666-77.
Beltran H
,
Yelensky R
,
Frampton GM
,
Park K
,
Downing SR
,
MacDonald TY
,
Jarosz M
,
Lipson D
,
Tagawa ST
,
Nanus DM
et al.
. 2013.
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
.
Eur Urol. 63(5):920-6.
2012
Prensner JR
,
Rubin MA
,
Wei JT
,
Chinnaiyan AM
. 2012.
Beyond PSA: the next generation of prostate cancer biomarkers.
.
Sci Transl Med. 4(127):127rv3.
Rubin MA
. 2012.
ETS rearrangements in prostate cancer.
.
Asian J Androl. 14(3):393-9.
Barbieri CE
,
Baca SC
,
Lawrence MS
,
Demichelis F
,
Blattner M
,
Theurillat J-P
,
White TA
,
Stojanov P
,
Van Allen E
,
Stransky N
et al.
. 2012.
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
.
Nat Genet. 44(6):685-9.
Demichelis F
,
Setlur SR
,
Banerjee S
,
Chakravarty D
,
Chen JYun Helen
,
Chen CX
,
Huang J
,
Beltran H
,
Oldridge DA
,
Kitabayashi N
et al.
. 2012.
Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.
.
Proc Natl Acad Sci U S A. 109(17):6686-91.
« first
‹ previous
1
2
(current)
3
4
5
next ›
last »